CTS vs TMO · P/E 22, rev $541.3M vs P/E 24, rev $44.56B
CTS Corporation (CTS) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
CTS Corporation (CTS) is a electronic components company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CTS revenue for 2025-12-31 was $541.3M. Net income was $65.3M. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. CTS currently screens at market cap $1.30B and trailing P/E 22.1.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CTS currently screens at market cap $1.30B and trailing P/E 22.1. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CTS and TMO stock pages for the full models.
Not investment advice.